[Federal Register Volume 88, Number 198 (Monday, October 16, 2023)]
[Notices]
[Pages 71366-71367]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22777]



[[Page 71366]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-24-1359]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``National Survey of Syringe Services 
Programs (NSSSP)'', to the Office of Management and Budget (OMB) for 
review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
May 4, 2023, to obtain comments from the public and affected agencies. 
CDC received no public comments related to the previous notice. This 
notice serves to allow an additional 30 days for public and affected 
agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    The National Survey of Syringe Services Programs (NSSSP) (OMB 
Control No. 0920-1359, Exp. 12/31/2024)--Revision--National Center for 
HIV, Viral Hepatitis, STD, TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The primary purpose of the National Survey of Syringe Services 
Programs (NSSSP) is to strengthen and improve the ability of CDC and 
local and state partners to monitor and evaluate syringe services 
programs (SSPs) nationally, with the overall goal of supporting, 
sustaining, and improving SSPs nationwide and reducing infectious 
disease and other harms related to drug use. Findings from the 2020-
2021 survey successfully characterized operational characteristics and 
services, funding resources, community relations, and key operational 
successes and challenges. The 2022 survey is currently being 
implemented. Revisions are being requested to address the increasing 
number of SSPs nationwide, the changing landscape of drug use 
nationally, additional SSP supplies and services provided, and ways in 
which SSPs are developing strategies to address the needs of people who 
use drugs (PWUD).
    The project will include all SSPs that are listed in a publicly 
available directory of all known SSPs in the United States maintained 
by the North American Syringe Exchange Network (NASEN; https://nasen.org). The project will also include SSPs in NASEN's directory 
that do not wish to be publicly listed but have agreed to be contacted 
for research purposes, SSPs belonging to NASEN's buyers' club that are 
not part of the directory, respondents to prior RTI Arnold Ventures 
Surveys of SSPs that are not part of NASEN's directory, and other SSPs 
proactively identified through searching state health department 
websites, funding agencies, state and regional networks, regional 
conferences, partner organization networks or webinars and via social 
media. SSPs will be sent a letter of invitation to participate in a 35-
minute program survey. Participating programs will have the option of 
completing the survey via different modalities to enhance feasibility 
and comfort in completing the survey, for example via the Research 
Electronic Data Capture (REDCap) or a similarly secure web-based 
application. Other modalities for survey administration will include a 
coordinated telephone or videoconferencing interview. SSPs will be sent 
reminder letters for a six-month data collection period. SSPs that do 
not respond to prior reminders will be sent one final reminder, and if 
the SSP still does not want to participate, one (optional) question on 
why the SSP did not complete the survey will be offered.
    The survey will include questions on operational characteristics 
and services, funding resources, community relations, and key 
operational successes and challenges. Approximately 1000 SSPs will be 
able to participate in the survey. CDC anticipates that 20% of SSPs 
will decline to complete the survey, yielding 800 completed surveys per 
year. However, given that it is challenging to predict future response 
rates, we are requesting enough burden hours to allow 100% of SSPs to 
respond to the survey. CDC estimates that it will take 35 minutes to 
complete the survey, regardless of how the respondent chooses to 
complete it (i.e., self-administered online or interviewer-administered 
by phone or videoconferencing). CDC estimates that it will take SSPs 
that do not respond to the initial survey invitation two minutes to 
respond to the additional question.
    CDC requests OMB approval for an estimated 616 annual burden hours. 
There are no other costs to respondents other than their time.

Estimated Annualized Burden Hours

----------------------------------------------------------------------------------------------------------------
                                                                                   Number of      Average burden
             Respondent                        Form              Number of       responses per     per response
                                                                respondents       respondent        (in hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs..............  National Syringe                  1000                 1            35/60
                                       Services Program
                                       Evaluation Survey.

[[Page 71367]]

 
Non-responding SSPs.................  Non-Response Survey               1000                 1             2/60
                                       Item.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2023-22777 Filed 10-13-23; 8:45 am]
BILLING CODE 4163-18-P